A Case Report of Fatal Caffeine Intoxication : Nonspecific Postmortem Distribution
Article content
Abstract
Caffeine, a mild central nervous system (CNS) stimulant present in coffee beans, cocoa beans, and tea leaves, can pose a threat in significant quantities, leading to severe health complications like arrhythmia, tachycardia vomiting, convulsions, coma, and, in extreme cases, death.
We present a case involving the tragic demise of a young woman who took her own life by consuming a sleepiness-preventing medication purchased online, containing caffeine. The autopsy revealed pulmonary edema, congestion, and cutaneous emphysema. The stomach contents included a dark-brown viscous fluid with remnants of tablets and food. Toxicological analysis indicated elevated caffeine levels in various body tissues: femoral blood (195 mg/L), brain (115 µg/g), lung (293 mg/g), liver (202 mg/g), spleen (692 mg/g), kidney (288 µg/g), gall bladder (bile juice) (1500 µg/g), skeletal muscle (163 µg/g), small intestine (236 µg/g), and myocardial muscle (682 µg/g). Due to the presence of caffeine tablets in the stomach, the concentration was exceptionally high and therefore not quantified. The highest concentration of caffeine was found in the bile (1500 µg/g). The gas chromatography mass spectrometry (GC/MS) method used was validated according to the GTFCh guidelines. This case emphasizes the importance of caution and highlights the study's recommendation to address the toxicity risks associated with substances containing high caffeine concentrations. The suggestion is to include caffeine concentration assessments in routine forensic toxicological tests for all cases. In this case the cause of death was determined to be caffeine intoxication, with no trace of ethyl alcohol, drugs, pesticides hydrocarbons, or organic solvents detected in the body samples.
Keywords
Forensic sciences, Caffeine, Overdose, Suicidal poisoning, Distribution, GC/MS.
Downloads
References
Baselt RC, "Disposition of Toxic Drugs and Chemicals in Man", 7th ed., Biomedical Publications, Foster City, CA, 2004; 157–159.
McCusker RR, Goldberger BA, Cone EJ. Caffeine content of specialty coffees. J Anal Toxicol. 2003 Oct;27(7):520-2. DOI: 10.1093/jat/27.7.520.
O'Connell SE, Zurzola FJ. Rapid quantitative liquid chromatographic determination of caffeine levels in plasma after oral dosing. J Pharm Sci. 1984 Jul;73(7):1009-11. DOI: 10.1002/jps.2600730742.
Moffatt AC, Osselton MD, Widdop B, Galichet LY, “Clarke’s Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids and Postmortem Material”, 3rd ed., Pharmaceutical Press, London, 2004; 736–738.
Kamijo Y, Takai M, Fujita Y, Usui K. A Retrospective Study on the Epidemiological and Clinical Features of Emergency Patients with Large or Massive Consumption of Caffeinated Supplements or Energy Drinks in Japan. Intern Med. 2018 Aug 1;57(15):2141-2146. DOI: 10.2169/internalmedicine.0333-17.
Cappelletti S, Piacentino D, Fineschi V, Frati P, Cipolloni L, Aromatario M. Caffeine-Related Deaths: Manner of Deaths and Categories at Risk. Nutrients. 2018 May 14;10(5):611. DOI: 10.3390/nu10050611.
Restek Application Note #59548. GC Analysis of Commonly Abused Inhalants in Blood Using Rtx BAC1 and Rtx BAC2 Columns.
Peters FT et. al. Guidelines and Recommendations of GTFCh, Appendix B, Requirements for the validation of analytical methods, Version 001, date 1st June 2009.
Dalpe-Scott M, Degouffe M, Garbutt D, Drost M. A comparison of drug concentrations in postmortem cardiac and peripheral blood in 320 cases. Can. Soc. For. Sci. J. 1995; 28(2): 113– 121. DOI: 10.1080/00085030.1995.10757474.
Kerrigan S, Lindsey T. Fatal caffeine overdose: two case reports. Forensic Sci Int. 2005 Oct 4;153(1):67-9. DOI: 10.1016/j.forsciint.2005.04.016.
McGee MB. Caffeine poisoning in a 19-year-old female. J Forensic Sci. 1980 Jan;25(1):29-32. DOI: 10.1520/JFS10932J.
Kerrigan S, Lindsey T. Fatal caffeine overdose: two case reports. Forensic Sci Int. 2005 Oct 4;153(1):67-9. DOI: 10.1016/j.forsciint.2005.04.016.
O’Connell S E, Zurzola F J. Rapid quantitative liquid chromatographic determination of caffeine levels in plasma after oral dosing, J. Pharm. Sci. 1984;73:1009–1011. DOI: 10.1002/jps.2600730742
Benowitz N L. Clinical pharmacology of caffeine, Ann. Rev. Med. 1990;41:277–288. DOI: 10.1146/annurev.me.41.020190.001425.
Karch S B, Caffeine, in: Karch S B (Ed.), Karch’s Pathology of Drug Abuse, third ed., CRC Press, FL, 2002 (Section 2.2).
Baselt R C, Caffeine, in: Disposition of Toxic Drugs and Chemicals in Man, ninth ed., Biomedical Publications, CA, 2011.
Arnaud M J. (2011). Pharmacokinetics and Metabolism of Natural Methylxanthines in Animal and Man. In: Methylxanthines. Handbook of Experimental Pharmacology, vol 200. Springer, Berlin, Heidelberg. DOI: 10.1007/978-3-642-13443-2_3.
Carrillo J A, Benitez, J. Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications. Clin Pharmacokinet. 2000;39:127–153. DOI: 10.2165/00003088-200039020-00004.
Sawynok J, Yaksh T L. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action, Pharmacol. Rev. 1993;45:43–85. PMID: 8475169.
Kaplan, G B, Greenblatt D J, Ehrenberg B L, Goddard JE, Cotreau M M, Harmatz J S and Shader R I. Dose-Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans. The Journal of Clinical Pharmacology. 1997;37:693-703. DOI: 10.1002/j.1552-4604.1997.tb04356.x
Dorne J L C M, Walton K, Renwick A G. Uncertainty factors for chemical risk assessment: human variability in the pharmacokinetics of CYP1A2 probe substrates, Food and Chemical Toxicology. 2001;39(1): 681-696. DOI: 10.1016/S0278-6915(01)00005-9.
Faidon M & Stavros A K. Caffeine Use in Sports, Pharmacokinetics in Man, and Cellular Mechanisms of Action, Critical Reviews in Food Science and Nutrition. 2005;45(7-8):535-562. DOI: 10.1080/1040-830491379245.
Ishikawa T, Yuasa I, Endoh M. Non specific drug distribution in an autopsy case report of fatal caffeine intoxication. Leg Med (Tokyo). 2015 Nov;17(6):535-8. DOI: 10.1016/j.legalmed.2015.11.002.
Yamamoto T, Yoshizawa K, Kubo S, Emoto Y, Hara K, Waters B, Umehara T, Murase T, Ikematsu K. Autopsy report for a caffeine intoxication case and review of the current literature. J Toxicol Pathol. 2015 Jan;28(1):33-6. DOI: 10.1293/tox.2014-0044.
Carlo A et. al. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the safety of caffeine. EFSA Journal, 2015;13(5):4102. DOI: 10.2903/j.efsa.2015.4102
Banerjee P, Ali Z, Levine B, Fowler DR. Fatal caffeine intoxication: a series of eight cases from 1999 to 2009. J Forensic Sci. 2014 May;59(3):865-8. DOI: 10.1111/1556-4029.12387.
Shan J, Yuling Z, Hongwei Q, Bin D, Jie C, Mengxiang S. UPLC-MS/MS method for the simultaneous quantification of caffeine and illicit psychoactive drugs in hair using a single-step high-speed grinding extraction – Insights into a cut-off value for caffeine abuse. Journal of Pharmaceutical and Biomedical Analysis. 2022;209:114489. DOI.org/10.1016/j.jpba.2021.114489.
Article details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
You must read and accept the copyright terms and conditions(click here for copyright terms).